Update Research in Psoriasis
Xiaoning Yan
Shaanxi Province Hospital of Traditional Chinese Medicine, Xi’an, China.
Jiawei Wu
Shaanxi University of Chinese Medicine, Xi’an, China.
Fuyong Jiao *
Children’s Hospital of Shaanxi Provincial People’s Hospital, Xi’an, China.
*Author to whom correspondence should be addressed.
Abstract
Psoriasis is now more recognized as a chronic-lymphocyte mediated inflammatory and proliferous skin disease. In European countries, the prevalence of psoriasis is 1%~3%, so the study of psoriasis is very important. With the study of immune pathogenesis and the progress of genetic engineering technology, it has been gradually developed a wide range of biological agents, And achieved good results in clinical trials or clinical treatment. This paper discusses the typical clinical manifestations, genetic research and treatment of psoriasis.
Keywords: Psoriasis, clinical treatment, chronic inflammatory disease, skin disease